论文部分内容阅读
目的:浅谈洛汀新合并硝苯地平缓释片在老年糖尿病合并高血压治疗中的影响。方法:随机抽取本单位2015年1月至2017年6月治疗的130例老年糖尿病合并高血压患者进行研究,将患者随机分为实验组与对照组,每组各65例。实验组病患予以洛汀新+硝苯地平缓释片治疗,对照组予以硝苯地平缓释片治疗,对比两组治疗后的DBP与SBP指标、治疗效果并作评价。结果:对比两组病患治疗后的DBP与SBP指标发现,实验组病患的DBP与SBP水平均明显低于对照组,且两组数据具显著性差异(P<0.05);实验组与对照组的总有效率分别为95.38%、72.31%,两组数据的差异有显著性,存在统计学意义(P<0.05)。结论:洛汀新合并硝苯地平缓释片在老年糖尿病合并高血压治疗中的疗效显著,可显著降低DBP与SBP水平,改善病情。
Objective: To discuss the effect of Lotensin combined with nifedipine sustained release tablets in the treatment of senile diabetes complicated with hypertension. Methods: A total of 130 elderly patients with diabetes mellitus complicated with hypertension who were treated in our hospital from January 2015 to June 2017 were randomly selected for study. The patients were randomly divided into experimental group and control group with 65 cases in each group. Patients in the experimental group were treated with Lotensin + nifedipine. The control group was treated with nifedipine sustained release tablets. The DBP and SBP indexes were compared between the two groups after treatment. The therapeutic effect was evaluated and evaluated. Results: Compared with DBP and SBP after treatment, DBP and SBP in experimental group were significantly lower than those in control group (P <0.05). The experimental group and control group The total effective rates of the two groups were 95.38% and 72.31%, respectively. There was significant difference between the two groups (P <0.05). Conclusion: The combination of Lotensin and nifedipine sustained-release tablets has a significant effect in the treatment of elderly patients with diabetes and hypertension, which can significantly reduce the levels of DBP and SBP and improve the condition.